CYTO   $0.3  -28.57% Market Open

Altamira Therapeutics Ltd
Total Cash 65.45K
totalCashPerShare 0.025
EBITDA
Total Debt 427.44K
quickRatio 0.152
currentRatio 0.427
Total Revenue
debtToEquity 6.765
Revenue/Share
ROA -0.57145
ROE -3.68779
grossProfits
freeCashflow -5.41M
operatingCashflow -7.58M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 1.71M
forwardPE -0.37124997
floatShares 2.65M
sharesOutstanding 3.78M
sharesShort 11.57K
sharesShortPriorMonth 82.02K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.00%
Short Ratio help_outline 0.20%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 2.366
Price To Book help_outline 0.21
earningsQuarterlyGrowth
netIncomeToCommon -7.91M
trailingEps 1.82%
forwardEps -1.36%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 5
lastUpdated Nov. 7, 2024, 5:12 a.m.